Typhoid Antibody Testing Market Players:
- IDL Biotech AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- LINEAR CHEMICALS, S.L.U
- Medical Innovation Ventures Sdn Bhd
- Thermo Fisher Scientific
- Nectar Lifesciences Ltd.
- DIALAB GmbH.
- BIOSYSTEMS S.A.
- Siemens Healthcare GmbH
- NanoEnTek
- CerTest Biotec S.L.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of typhoid antibody testing is assessed at USD 9.04 billion.
The global typhoid antibody testing market size was valued at over USD 8.42 billion in 2025 and is expected to expand at a CAGR of around 8.2%, surpassing USD 18.52 billion revenue by 2035.
Asia Pacific typhoid antibody testing market will hold around 41% share by 2035, driven by increasing typhoid cases and government-led awareness initiatives.
Key players in the market include IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
